ProPhase Labs, Inc. — Director's Dealing 2020

Jan 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2020-01-01

Reporting Person: GLECKEL LOUIS MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-01	Common Stock, par value $0.0005	A	5564	$2.02	Acquired	109894	Direct

Footnotes

F1: These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees.